Data / Form D filings / GENIE Therapeutics, Inc.
GENIE Therapeutics, Inc.: Form D filings
GENIE Therapeutics, Inc., a biotechnology company in Wilmington, DE, filed 2 Form D notices with the SEC in 2023. The latest, on November 17, 2023, reports an offering of no set size with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1207 DELAWARE AVENUE #1118, Wilmington, DE, 19806
- Phone
- (336) 416-6787
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1987607
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 17, 2023 | Amendment | Indefinite | $0 | 0 | Yet to occur | sec.gov | |
| Jul 27, 2023 | New notice | Indefinite | $50,000 | 1 | Jul 10, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Aaron Tabor | Executive Officer |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Nov 13, 2023 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GENIE Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.